In vitro human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) can differentiate into functional cardiomyocytes (CMs). Protocols for cardiac differentiation of hESCs and hiPSCs include formation of the three-dimensional cell aggregates called embryoid bodies (EBs). The traditional suspension method for EB formation from clumps of cells results in an EB population heterogeneous in size and shape. In this study we show that forced aggregation of a defined number of single cells on AggreWell plates gives a high number of homogeneous EBs that can be efficiently differentiated into functional CMs by application of defined growth factors in the media. For cardiac differentiation, we used three hESC lines and one hiPSC line. Our contracting EBs and the resulting CMs express cardiac markers, namely myosin heavy chain α and β, cardiac ryanodine receptor/calcium release channel, and cardiac troponin T, shown by real-time polymerase chain reaction and immunocytochemistry. Using Ca(2+) imaging and atomic force microscopy, we demonstrate the functionality of RyR2 to release Ca(2+) from the sarcoplasmic reticulum as well as reliability in contractile and beating properties of hESC-EBs and hiPSC-EBs upon the stimulation or inhibition of the β-adrenergic pathway.

Department of Biology Faculty of Medicine Masaryk University Brno Czech Republic

See more in PubMed

Nature. 2008 May 22;453(7194):524-8 PubMed

Cryobiology. 1990 Oct;27(5):539-46 PubMed

Stem Cells. 2008 Aug;26(8):1961-72 PubMed

J Embryol Exp Morphol. 1985 Jun;87:27-45 PubMed

Tissue Cell. 2013 Feb;45(1):54-60 PubMed

J Pharmacol Exp Ther. 1965 May;148:202-14 PubMed

Differentiation. 2008 Nov;76(9):958-70 PubMed

PLoS One. 2011 Apr 08;6(4):e18293 PubMed

Nat Rev Mol Cell Biol. 2012 Nov;13(11):713-26 PubMed

Acta Physiol Scand. 1958 Oct 28;44(1):55-66 PubMed

Stem Cells. 2008 Sep;26(9):2300-10 PubMed

PLoS One. 2012;7(5):e37559 PubMed

Eur Heart J. 2013 Jun;34(21):1575-86 PubMed

Biomaterials. 2010 Mar;31(7):1885-93 PubMed

Heart Vessels. 1997;Suppl 12:53-7 PubMed

Biophys J. 2005 Oct;89(4):2533-41 PubMed

Stem Cells. 2007 Apr;25(4):929-38 PubMed

Heart Vessels. 1997;Suppl 12:18-22 PubMed

Methods Mol Biol. 2013;946:523-33 PubMed

J Mol Cell Cardiol. 2011 Sep;51(3):280-7 PubMed

Biotechnol Prog. 2009 Jan-Feb;25(1):43-51 PubMed

Heart Vessels. 2013 Nov;28(6):785-94 PubMed

J Gen Physiol. 1968 Nov;52(5):750-9 PubMed

Stem Cells. 2010 Apr;28(4):661-73 PubMed

Biochem Biophys Res Commun. 2011 Dec 9;416(1-2):51-7 PubMed

Cell Stem Cell. 2011 Feb 4;8(2):228-40 PubMed

Int J Dev Biol. 2008;52(4):353-63 PubMed

Cryobiology. 1997 Nov;35(3):193-200 PubMed

Experientia. 1967 Jul 15;23(7):559 PubMed

Heart Vessels. 2014 May;29(3):396-403 PubMed

Stem Cell Rev Rep. 2011 Nov;7(4):976-86 PubMed

Stem Cells. 2005 Sep;23(8):1200-11 PubMed

PLoS One. 2011 Apr 01;6(4):e18037 PubMed

Nat Biotechnol. 2011 Oct 23;29(11):1011-8 PubMed

Aminophylline Induces Two Types of Arrhythmic Events in Human Pluripotent Stem Cell-Derived Cardiomyocytes

Oxygen Is an Ambivalent Factor for the Differentiation of Human Pluripotent Stem Cells in Cardiac 2D Monolayer and 3D Cardiac Spheroids

DMD Pluripotent Stem Cell Derived Cardiac Cells Recapitulate in vitro Human Cardiac Pathophysiology

Dystrophin Deficiency Leads to Genomic Instability in Human Pluripotent Stem Cells via NO Synthase-Induced Oxidative Stress

Post-Translational Modifications and Diastolic Calcium Leak Associated to the Novel RyR2-D3638A Mutation Lead to CPVT in Patient-Specific hiPSC-Derived Cardiomyocytes

HIF-1alpha Deficiency Attenuates the Cardiomyogenesis of Mouse Embryonic Stem Cells

Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools